UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A transient positive association between direct‐acting antiviral therapy for hepatitis C infection and drug‐related hospitalization among people who inject drugs: Self‐controlled case‐series analysis of national data

Addiction (Abingdon, England), 2024-02, Vol.119 (2), p.369-378

2024

Volltextzugriff (PDF)

Time‐dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct‐acting antiviral therapy of chronic hepatitis C

Journal of viral hepatitis, 2020-01, Vol.27 (1), p.28-35

2020

Volltextzugriff (PDF)

American Gastroenterological Association Institute Clinical Practice Update—Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection

Gastroenterology (New York, N.Y. 1943), 2017-05, Vol.152 (6), p.1578-1587

2017

Volltextzugriff (PDF)

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study

Journal of viral hepatitis, 2019-01, Vol.26 (1), p.83-92

2019

Volltextzugriff (PDF)

Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4

Journal of viral hepatitis, 2019-02, Vol.26 (2), p.263-270

2019

Volltextzugriff (PDF)

Magnetic resonance imaging‐based risk factors of hepatocellular carcinoma after direct‐acting antiviral therapy: A multicenter observational study

Hepatology research, 2024-01, Vol.54 (1), p.43-53

2024

Volltextzugriff (PDF)

The impact of HCV eradication by direct‐acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study

Liver international, 2019-03, Vol.39 (3), p.448-454

2019

Volltextzugriff (PDF)

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C‐infected patients treated with direct‐acting antivirals with and without pegylated interferon: A Belgian experience

Journal of viral hepatitis, 2017-11, Vol.24 (11), p.976-981

2017

Volltextzugriff (PDF)

Pre‐existing, treatment‐specific resistance‐associated substitutions in hepatitis C virus genotype 1 and 3 and viral RNA titers during treatment with direct‐acting antivirals

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2023-08, Vol.131 (8), p.426-433

2023

Volltextzugriff (PDF)

Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies

Journal of viral hepatitis, 2020-03, Vol.27 (3), p.243-260

2020

Volltextzugriff (PDF)

Association between hepatitis C virus infection and subsequent chronic inflammatory skin disease

Journal of dermatology, 2021-12, Vol.48 (12), p.1884-1891

2021

Volltextzugriff (PDF)

Hepatitis B surface antibody titres and hepatitis B reactivation with direct‐acting antiviral therapy for hepatitis C

Journal of viral hepatitis, 2021-02, Vol.28 (2), p.373-382

2021

Volltextzugriff (PDF)

Intention‐to‐treat assessment of glecaprevir + pibrentasvir combination therapy for patients with chronic hepatitis C in the real world

Hepatology research, 2019-12, Vol.49 (12), p.1365-1373

2019

Volltextzugriff (PDF)

Altered balance between collagen formation and degradation after successful direct‐acting antiviral therapy of chronic hepatitis C

Journal of viral hepatitis, 2021-02, Vol.28 (2), p.236-244

2021

Volltextzugriff (PDF)

Efficacy and safety of direct‐acting antivirals for hepatitis C in the elderly: A systematic review and meta‐analysis

Liver international, 2019-09, Vol.39 (9), p.1652-1660

2019

Volltextzugriff (PDF)

BK‐Virus and the Impact of Pre‐Emptive Immunosuppression Reduction: 5‐Year Results

American journal of transplantation, 2010-02, Vol.10 (2), p.407-415

2010

Volltextzugriff (PDF)

The Challenge of Treating Children With Hepatitis C Virus Infection

Journal of pediatric gastroenterology and nutrition, 2017-06, Vol.64 (6), p.851-854

2017

Volltextzugriff (PDF)

Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report

Transplant infectious disease, 2021-04, Vol.23 (2), p.e13466-n/a

2021

Volltextzugriff (PDF)

Deep sequence analysis of NS5A resistance‐associated substitution changes in patients reinfected with the hepatitis C virus after liver transplantation

Journal of viral hepatitis, 2020-05, Vol.27 (5), p.552-555

2020

Volltextzugriff (PDF)

HIV drug resistance: problems and perspectives

Infectious disease reports, 2013-06, Vol.5 (11), p.e5-e5

Pennings, Pleuni S.

2013

Volltextzugriff (PDF)

COVID-19: Progress in diagnostics, therapy and vaccination

Theranostics, 2020, Vol.10 (17), p.7821-7835

2020

Volltextzugriff (PDF)

Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal

Journal of nursing scholarship, 2020-03, Vol.52 (2), p.128-135

2020

Volltextzugriff (PDF)

The Apolipoprotein E neutralizing antibody inhibits SARS-CoV-2 infection by blocking cellular entry of lipoviral particles

MedComm (2020), 2023-10, Vol.4 (5), p.e400-e400

2023

Volltextzugriff (PDF)

Direct‐acting antiviral regimens are safe and effective in the treatment of hepatitis C in simultaneous liver–kidney transplant recipients

Clinical transplantation, 2018-03, Vol.32 (3), p.e13198-n/a

2018

Volltextzugriff (PDF)

The impact of single-nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct-acting antiviral drugs for hepatitis C infection

Biomedical reports, 2022-02, Vol.16 (2), p.9-9, Article 9

2022

Volltextzugriff (PDF)

1 – 25 von 80.105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70.427)
Mit Volltextzugriff
(60.330)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(73.932)
Japanisch
(8.075)
Französisch
(1.177)
Chinesisch
(1.017)
Deutsch
(925)
Spanisch
(901)
Russisch
(843)
Portugiesisch
(427)
Polnisch
(253)
Italienisch
(194)
Koreanisch
(161)
Ungarisch
(110)
Niederländisch
(109)
Dänisch
(73)
Schwedisch
(50)
Rumänisch
(49)
Norwegisch
(48)
Tschechisch
(45)
Croatian
(43)
Türkisch
(36)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(68.583)
Science & Technology
(62.973)
Life Sciences & Biomedicine
(60.311)
Antiviral Agents - Therapeutic Use
(42.313)
Male
(30.563)
Female
(30.413)
Antiviral Agents
(26.473)
Adult
(23.377)
Infectious Diseases
(21.161)
Biological And Medical Sciences
(20.570)
Middle Aged
(20.465)
Medical Sciences
(19.988)
Pharmacology. Drug Treatments
(14.117)
Treatment Outcome
(13.965)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(12.702)
Virology
(12.342)
Hepatitis C, Chronic - Drug Therapy
(11.759)
Hiv Infections - Drug Therapy
(11.490)
Pharmacology & Pharmacy
(11.373)
Viral Diseases
(11.216)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(73.128)
EZB Electronic Journals Library
(38.548)
Ingenta
(35.210)
Lippincott E Journal Collection
(34.950)
IngentaConnect Journals
(21.433)
NUS Single-Journal Subscriptions
(15.684)
Elsevier ScienceDirect Journals Complete
(12.689)
Wiley-Blackwell Journals
(11.092)
Wiley Online Library
(8.788)
EZB-NALI5-00465 Elsevier Archive NL
(7.871)
SpringerNature Journals
(7.798)
Oxford journals
(3.960)
JSTOR
(3.877)
Oxford Journals 2020 Medicine
(3.611)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(3.491)
Access via Taylor & Francis
(3.111)
Taylor & Francis
(2.727)
SAGE Journals
(2.698)
Nexis Uni (LexisNexis)
(2.559)
Nature - Journals : Nature ; Nature Climate Change
(2.199)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Aids
(2.534)
Antiviral Research
(1.578)
Plos One
(1.435)
Antiviral Therapy
(1.390)
Clinical Infectious Diseases
(1.367)
Antimicrobial Agents And Chemotherapy
(1.326)
The Journal Of Infectious Diseases
(1.155)
Journal Of Hepatology
(1.134)
Clinical Infectious Diseases/clinical Infectious Diseases
(1.061)
Journal Of Viral Hepatitis
(1.060)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A transient positive association between direct‐acting antiviral therapy for hepatitis C infection and drug‐related hospitalization among people who inject drugs: Self‐controlled case‐series analysis of national data

Time‐dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct‐acting antiviral therapy of chronic hepatitis C

American Gastroenterological Association Institute Clinical Practice Update—Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study

Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4

Magnetic resonance imaging‐based risk factors of hepatocellular carcinoma after direct‐acting antiviral therapy: A multicenter observational study

The impact of HCV eradication by direct‐acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C‐infected patients treated with direct‐acting antivirals with and without pegylated interferon: A Belgian experience

Pre‐existing, treatment‐specific resistance‐associated substitutions in hepatitis C virus genotype 1 and 3 and viral RNA titers during treatment with direct‐acting antivirals

Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies

Association between hepatitis C virus infection and subsequent chronic inflammatory skin disease

Hepatitis B surface antibody titres and hepatitis B reactivation with direct‐acting antiviral therapy for hepatitis C

Intention‐to‐treat assessment of glecaprevir + pibrentasvir combination therapy for patients with chronic hepatitis C in the real world

Altered balance between collagen formation and degradation after successful direct‐acting antiviral therapy of chronic hepatitis C

Efficacy and safety of direct‐acting antivirals for hepatitis C in the elderly: A systematic review and meta‐analysis

BK‐Virus and the Impact of Pre‐Emptive Immunosuppression Reduction: 5‐Year Results

The Challenge of Treating Children With Hepatitis C Virus Infection

Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report

Deep sequence analysis of NS5A resistance‐associated substitution changes in patients reinfected with the hepatitis C virus after liver transplantation

HIV drug resistance: problems and perspectives

COVID-19: Progress in diagnostics, therapy and vaccination

Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal

The Apolipoprotein E neutralizing antibody inhibits SARS-CoV-2 infection by blocking cellular entry of lipoviral particles

Direct‐acting antiviral regimens are safe and effective in the treatment of hepatitis C in simultaneous liver–kidney transplant recipients

The impact of single-nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct-acting antiviral drugs for hepatitis C infection

Suchergebnisse filtern